Domestic Protectionism Takes Center Stage in U.S. Trade Policy Shifts

The last several days have marked a period of rapid action and policy shifts from United States Trade Representative Jamieson Greer. A central development was Greer’s extensive speech on industrial policy at last week’s Reindustrialize Summit in Detroit. He stressed the administration’s protectionist approach and criticized economic elites who he claims have benefited at the expense of American manufacturing. Observers, like the Cato Institute, noted Greer’s long-standing ties to the domestic steel industry, as both a private attorney and government official, and reflected on how these connections continue to shape trade policy decisions. Tariff moves have been a defining story. The Trump administration recently announced updated reciprocal tariff rates, effective August first, raising costs on imports from major trading partners such as Brazil, Canada, and the European Union. Canada, for instance, now faces a thirty five percent tariff on its goods. There is friction with Canada as negotiations continue, with Prime Minister Mark Carney acknowledging that Canada may have to live with the tariffs as part of any eventual deal, according to a report in the National Law Review. Greer’s office has also initiated a Section three hundred one investigation into Brazil’s trade practices, following a directive from President Trump in response to concerns over Brazilian tariffs, digital trade, and environmental policies. This investigation could lead to tariffs as high as fifty percent on Brazilian imports. Key areas under review include digital trade, intellectual property, and illegal deforestation. Stakeholder hearings and public comments are underway, with companies monitoring effects on supply chains and market access, as highlighted by legal analysis in JD Supra. Trade agreements have been struck with Japan, the Philippines, Indonesia, and Vietnam in recent days. The U.S. Japan deal, announced earlier this week, sets a fifteen percent tariff rate—lower than threatened levels but notably higher than previous rates. According to ABC News, the White House hailed it as a “massive deal,” though specifics remain forthcoming. These agreements are lowering some tariffs from their initially proposed highs in exchange for concessions, but many U.S. industries are still awaiting detailed terms and the certainty of finalized deals. On Capitol Hill, eighteen Republican Senators sent a letter applauding efforts by Secretary of Commerce Howard Lutnick and Jamieson Greer to ensure that foreign nations contribute more to the costs of U.S. pharmaceutical research and development. The Trade Alliance to Promote Prosperity highlighted the Senate’s call for greater enforcement of pharmaceutical pricing commitments during trade negotiations and urged the administration to assign a senior official at the U.S. Trade Representative’s office to focus on this issue. Domestically focused lawmakers are also pressing Greer for action. Representatives Celeste Maloy and Burgess This content was created in partnership and with the help of Artificial Intelligence AI.